Atlas Trials

Acerta Pharma BV

41 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Acerta Pharma BV

RecordFirmDate
A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312) (NCT04529772)Acerta Pharma BV2020-10-08
Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19 (NCT04497948)Acerta Pharma BV2020-09-21
A Study to Evaluate the Effect of Pharmacokinetics (PK) of Acalabrutinib and Its Active Metabolite (ACP-5862) When Administered Alone and With Moderate CYP3A4 Inhibitors Fluconazole or Isavuconazole in Healthy Adult Participants (NCT05140096)Acerta Pharma BV2020-01-03
Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL (NCT03836261)Acerta Pharma BV2019-02-25
Investigate the Influence of Severe Hepatic Impairment on the Pharmacokinetics of Acalabrutinib and Its Metabolite (NCT03968848)Acerta Pharma BV2018-11-12
Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study) (NCT03527147)Acerta Pharma BV2018-06-19
A Study of AZD6738 and Acalabrutinib in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) (NCT03328273)Acerta Pharma BV2018-01-31

Track Acerta Pharma BV automatically

Every clearance here is in the API, with alerts when new ones post.